Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893225208> ?p ?o ?g. }
- W2893225208 endingPage "5233" @default.
- W2893225208 startingPage "5224" @default.
- W2893225208 abstract "Herein, we developed a fully polymerizable, peptide-targeted, camptothecin polymeric prodrug system. Two prodrug monomers were synthesized via esterification of campothecin (20Cam) and 10-hydroxycamptothecin (10Cam) with mono-2-(methacryloyloxy)ethyl succinate (SMA) resulting in polymerizable forms of the aliphatic ester- and aromatic ester-linked drugs respectively. These monomers were then incorporated into zwitterionic polymers via RAFT copolymerization of the prodrug monomers with a tert-butyl ester protected carboxy betaine monomer. Subsequent deprotection of the tert-butyl residues with TFA yielded carboxy betaine methacrylate (CBM) scaffolds with controlled prodrug incorporation. Reverse phase HPLC was then employed to establish drug release kinetics in human serum at 37 oC for the resultant polymeric prodrugs. Copolymers containing 10Cam residues linked via aromatic esters showed faster hydrolysis rates with 59 % drug released at 7 days, while copolymers with Cam residues linked via aliphatic esters showed only 28 % drug release over the same time period. These differences in drug release kinetics were then shown to correlate with large differences in cytotoxic activity in SKOV3 ovarian cancer cell cultures. At 72 hours, the IC50s of aromatic- and aliphatic- ester linked prodrugs were 56 nM and 4776 nM, respectively. An EGFR-targeting peptide sequence, GE11, was then directly incorporated into the polymeric prodrugs via RAFT copolymerization of the polymeric prodrugs with a peptide macronomer. The GE11-targeted polymeric prodrugs showed enhanced targeting and cytotoxic activity in SKOV3 cell cultures relative to untargeted polymers containing the negative control sequence HW12. Following pulse-chase treatment (15 min, 37 °C), the 72 hour IC50 of GE11 targeted prodrug was determined to be 1597 nM, in contrast to 3399 nM for the non-targeted control." @default.
- W2893225208 created "2018-10-05" @default.
- W2893225208 creator A5038610179 @default.
- W2893225208 creator A5042529401 @default.
- W2893225208 creator A5057154275 @default.
- W2893225208 creator A5064390595 @default.
- W2893225208 creator A5070360554 @default.
- W2893225208 date "2018-01-01" @default.
- W2893225208 modified "2023-10-15" @default.
- W2893225208 title "Fully synthetic macromolecular prodrug chemotherapeutics with EGFR targeting and controlled camptothecin release kinetics" @default.
- W2893225208 cites W1965151156 @default.
- W2893225208 cites W1968583232 @default.
- W2893225208 cites W1970704467 @default.
- W2893225208 cites W2000749669 @default.
- W2893225208 cites W2007649418 @default.
- W2893225208 cites W2011118089 @default.
- W2893225208 cites W2012466100 @default.
- W2893225208 cites W2028745823 @default.
- W2893225208 cites W2031700322 @default.
- W2893225208 cites W2038756260 @default.
- W2893225208 cites W2041061652 @default.
- W2893225208 cites W2043696829 @default.
- W2893225208 cites W2046308571 @default.
- W2893225208 cites W2053640312 @default.
- W2893225208 cites W2066892610 @default.
- W2893225208 cites W2070750058 @default.
- W2893225208 cites W2074649834 @default.
- W2893225208 cites W2076226743 @default.
- W2893225208 cites W2081246207 @default.
- W2893225208 cites W2081477031 @default.
- W2893225208 cites W2082511916 @default.
- W2893225208 cites W2083661375 @default.
- W2893225208 cites W2102449174 @default.
- W2893225208 cites W2118795798 @default.
- W2893225208 cites W2133605826 @default.
- W2893225208 cites W2143452366 @default.
- W2893225208 cites W2146639342 @default.
- W2893225208 cites W2161817637 @default.
- W2893225208 cites W2169143154 @default.
- W2893225208 cites W2171067659 @default.
- W2893225208 cites W2176406695 @default.
- W2893225208 cites W2260661407 @default.
- W2893225208 cites W2382809884 @default.
- W2893225208 cites W2440824789 @default.
- W2893225208 cites W2508757991 @default.
- W2893225208 cites W2514700932 @default.
- W2893225208 cites W2594451304 @default.
- W2893225208 cites W2607212249 @default.
- W2893225208 cites W2738212012 @default.
- W2893225208 cites W2775803967 @default.
- W2893225208 cites W4232798708 @default.
- W2893225208 cites W639198359 @default.
- W2893225208 doi "https://doi.org/10.1039/c8py01047a" @default.
- W2893225208 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36660314" @default.
- W2893225208 hasPublicationYear "2018" @default.
- W2893225208 type Work @default.
- W2893225208 sameAs 2893225208 @default.
- W2893225208 citedByCount "12" @default.
- W2893225208 countsByYear W28932252082019 @default.
- W2893225208 countsByYear W28932252082020 @default.
- W2893225208 countsByYear W28932252082021 @default.
- W2893225208 countsByYear W28932252082022 @default.
- W2893225208 countsByYear W28932252082023 @default.
- W2893225208 crossrefType "journal-article" @default.
- W2893225208 hasAuthorship W2893225208A5038610179 @default.
- W2893225208 hasAuthorship W2893225208A5042529401 @default.
- W2893225208 hasAuthorship W2893225208A5057154275 @default.
- W2893225208 hasAuthorship W2893225208A5064390595 @default.
- W2893225208 hasAuthorship W2893225208A5070360554 @default.
- W2893225208 hasBestOaLocation W28932252082 @default.
- W2893225208 hasConcept C108215921 @default.
- W2893225208 hasConcept C132050475 @default.
- W2893225208 hasConcept C15920480 @default.
- W2893225208 hasConcept C166940927 @default.
- W2893225208 hasConcept C178790620 @default.
- W2893225208 hasConcept C185592680 @default.
- W2893225208 hasConcept C21951064 @default.
- W2893225208 hasConcept C2779281246 @default.
- W2893225208 hasConcept C2779682216 @default.
- W2893225208 hasConcept C521977710 @default.
- W2893225208 hasConcept C55493867 @default.
- W2893225208 hasConcept C9132879 @default.
- W2893225208 hasConceptScore W2893225208C108215921 @default.
- W2893225208 hasConceptScore W2893225208C132050475 @default.
- W2893225208 hasConceptScore W2893225208C15920480 @default.
- W2893225208 hasConceptScore W2893225208C166940927 @default.
- W2893225208 hasConceptScore W2893225208C178790620 @default.
- W2893225208 hasConceptScore W2893225208C185592680 @default.
- W2893225208 hasConceptScore W2893225208C21951064 @default.
- W2893225208 hasConceptScore W2893225208C2779281246 @default.
- W2893225208 hasConceptScore W2893225208C2779682216 @default.
- W2893225208 hasConceptScore W2893225208C521977710 @default.
- W2893225208 hasConceptScore W2893225208C55493867 @default.
- W2893225208 hasConceptScore W2893225208C9132879 @default.
- W2893225208 hasFunder F4320332161 @default.
- W2893225208 hasIssue "42" @default.
- W2893225208 hasLocation W28932252081 @default.
- W2893225208 hasLocation W28932252082 @default.